Arginine starvation has been shown to impair mitochondrial respiratory function in ASS1-deficient breast cancer cells [43], suggesting that arginine starvation therapy such as pegylated recombinant arginine deiminase (ADI-PEG20) could be an option for patients with low ASS1 expression [44]. Here, ASS1 is linked to breast cancer.